New Key Statistics Module, Z-Score and F-Score
GREY:ZRPHF Key Ratios
| Market Cap $ M | 870.23 |
| Enterprise Value $ M | 870.23 |
| P/E(ttm) | 10.71 |
| PE Ratio without NRI | 11.75 |
| Forward PE Ratio | 10.80 |
| Price/Book | 1.21 |
| Price/Sales | 1.23 |
| Price/Free Cash Flow | 11.67 |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | -- |
| EPS (TTM) $ | -- |
| Beneish M-Score | -2.44 |
| 10-y EBITDA Growth Rate % | 7.50 |
| 5-y EBITDA Growth Rate % | 18.40 |
| y-y EBITDA Growth Rate % | 27.60 |
| EV-to-EBIT | 10.15 |
| EV-to-EBITDA | 10.15 |
| PEG | 0.64 |
| Shares Outstanding M | 46.29 |
| Net Margin (%) | 11.45 |
| Operating Margin % | 13.43 |
| Pre-tax Margin (%) | 14.72 |
| Quick Ratio | 0.79 |
| Current Ratio | 1.06 |
| ROA % (ttm) | 6.22 |
| ROE % (ttm) | 12.32 |
| ROIC % (ttm) | 5.94 |
| Dividend Yield % | -- |
| Altman Z-Score | 2.12 |
ZRPHF Number of Guru Trades
ZRPHF Volume of Guru Trades
Gurus Latest Trades with GREY:ZRPHF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
GREY:ZRPHF is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Zeria Pharmaceutical Co Ltd Insider Transactions
No Available Data
News about GREY:ZRPHF
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers